Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
5.20
-0.02 (-0.38%)
May 5, 2026, 4:00 PM EDT - Market closed

Opus Genetics Revenue

In the year 2025, Opus Genetics had annual revenue of $14.20M with 29.15% growth. Opus Genetics had revenue of $3.87M in the quarter ending December 31, 2025, a decrease of -10.16%.

Revenue (ttm)
$14.20M
Revenue Growth
+29.15%
P/S Ratio
26.15
Revenue / Employee
$507,000
Employees
28
Market Cap
371.29M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.20M3.20M29.15%
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 200875.00K--
Dec 31, 200775.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition